Taken together, these findings suggest that expression of cadherin-17 promotes the metastatic activity of the highly bone marrow metastatic breast cancer cells in our model, and that cadherin-17 expression may be a useful marker of bone marrow metastasis in breast cancer. Here, CDH17 is linked to breast carcinoma.